|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Allon Therapeutics Inc., of Vancouver, British Columbia, was granted a patent covering additional composition of matter for products in its ADNP platform. Claims relate to the nucleic acid composition of its neuroprotective peptide candidates AL-108 and AL-208, which are in Phase II trials.
BioMicro Systems, of Salt Lake City, was awarded U.S. Patent No. 7,223,363, or the "MAUI Hybridization System Patent," which covers the invention of a microfluidic interface with microarrays to enable researchers the ability to achieve a three- to 10-fold increase in sensitivity and consistent/reproducible results compared to traditional coverslip or static microarray ...
Related newspaper, magazine, and journal articles:
|
|
Article: U.S. PATENT DISCLOSURES
BIOWORLD Today;
August 10, 1998 ;
700+ words
... ... received patent No. 5,769 ... recently issued patents covering aspects ... gene therapy. Patent No. 5,763,270, titled "Plasmid for ... to the three patents. * Guilford ... Baltimore, received patent No. 5,786,378, titled "Heterocyclic ...
|
|